Immunological aspects of epilepsyAARLI, J. A.Brain & development (Tokyo. 1979). 1993, Vol 15, Num 1, pp 41-49, issn 0387-7604Article

Immunoglobulins in epilepsyAARLI, J. A.Springer seminars in immunopathology. 1985, Vol 8, Num 1-2, pp 5-27, issn 0344-4325Article

Late-onset myasthenia gravis : A changing sceneAARLI, J. A.Archives of neurology (Chicago). 1999, Vol 56, Num 1, pp 25-27, issn 0003-9942Article

Trygge Andersen : epileptic hallucinations in the 1890s, fact or fiction ?AARLI, J. A.Epilepsia (Copenhagen). 1995, Vol 36, Num 3, pp 308-315, issn 0013-9580Article

The cerebrospinal fluid in myasthenia gravisTHORLACIUS, S; AARLI, J. A.Acta neurologica scandinavica. 1985, Vol 72, Num 4, pp 432-436, issn 0001-6314Article

Myasthenia gravis: difference between thymoma-associated antibodies and cross-striational skeletal muscle antibodiesGILHUS, N. E; AARLI, J. A; MATRE, R et al.Neurology. 1984, Vol 34, Num 2, pp 246-249, issn 0028-3878Article

CA-antibody: an immunological marker of thymic neoplasia in myasthenia gravis?AARLI, J. A; GILHUS, N. E; MOFSTAD, H et al.Acta neurologica scandinavica. 1987, Vol 76, Num 1, pp 55-57, issn 0001-6314Article

Myasthenia gravis. Antibodies to skeletal muscle cell surface antigensGILHUS, N. E; AARLI, J. A; MATRE, R et al.Journal of neuroimmunology. 1983, Vol 5, Num 3, pp 239-249, issn 0165-5728Article

Sinemet CR in the treatment of patients with Parkinson's disease already on long-term treatment with levodopaAARLI, J. A; GILHUS, N. E.Neurology. 1990, Vol 39, Num 11, pp 82-85, issn 0028-3878, 4 p., SUPLT2Conference Paper

Myasthenia gravis: the specificities of skeletal muscle and thymus antibodiesGILHUS, N. E; AARLI, J. A; MATRE, R et al.Acta neurologica scandinavica. 1983, Vol 68, Num 5, pp 328-336, issn 0001-6314Article

Myasthenia gravis with thymona is not associated with an increased incidence of non-muscle autoimmune disordersAARLI, J. A; GILHUS, N. E; MATRE, R et al.Autoimmunity (Print). 1992, Vol 11, Num 3, pp 159-162, issn 0891-6934Article

Multiple sclerosis and mortality statisticsLARSEN, J. P; KVÅLE, G; AARLI, J. A et al.Acta neurologica scandinavica. 1985, Vol 71, Num 3, pp 237-241, issn 0001-6314Article

The clinical significance of spinal cord injuries in patients older than 60 years of ageHAGEN, E. M; AARLI, J. A; GRONNING, M et al.Acta neurologica scandinavica. 2005, Vol 112, Num 1, pp 42-47, issn 0001-6314, 6 p.Article

Myasthenia gravis: clinical, immunological, and therapeutic advancesROMI, F; GILHUS, N. E; AARLI, J. A et al.Acta neurologica scandinavica. 2005, Vol 111, Num 2, pp 134-141, issn 0001-6314, 8 p.Article

Influence of occupational diving upon the nervous system : an epidemiological studyTODNEM, K; NYLAND, H; KAMBESTAD, B. K et al.British journal of industrial medicine. 1990, Vol 47, Num 10, pp 708-714, issn 0007-1072, 7 p.Article

Plasma exchange in myasthenia gravis: clinical effectTHORLACIUS, S; AARLI, J. A; JACOBSEN, H et al.Acta neurologica scandinavica. 1985, Vol 72, Num 5, pp 464-468, issn 0001-6314Article

Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravisMYGLAND, Å; AARLI, J. A; MATRE, R et al.Journal of neurology, neurosurgery and psychiatry. 1994, Vol 57, Num 7, pp 843-846, issn 0022-3050Article

Epidemiology of amyotrophic lateral sclerosis in Hordaland county, western NorwayTYSNES, O.-B; VOLLSET, S. E; AARLI, J. A et al.Acta neurologica scandinavica. 1991, Vol 83, Num 5, pp 280-285, issn 0001-6314, 6 p.Article

Heart muscle antibodies in myasthenia gravisMIGLAND, Å; AARLI, J. A; HOFSTAD, H et al.Autoimmunity (Print). 1991, Vol 10, Num 4, pp 263-267, issn 0891-6934Article

Non-receptor muscle antibodies in myasthenia gravis are of IgG1 and IgG4 subclassesHOFSTAD, H; GILHUS, N. E; MATRE, R et al.Autoimmunity (Print). 1992, Vol 12, Num 4, pp 271-276, issn 0891-6934Article

Muscle antibodies in the cerebrospinal fluid from patients with myasthenia gravisTHORLACIUS, S; AARLI, J. A; GILHUS, N. E et al.Acta neurologica scandinavica. 1987, Vol 75, Num 6, pp 423-426, issn 0001-6314Article

Rabbit antiserum to a citric acid extract of human skeletal muscle staining thymomas from myasthenia gravis patientsGILHUS, N. E; AARLI, J. A; CHRISTENSSON, B et al.Journal of neuroimmunology. 1984, Vol 7, Num 1, pp 55-64, issn 0165-5728Article

Neuroborreliosis with vasculitis causing stroke-like manifestationsROMI, F; KRAKENES, J; AARLI, J. A et al.European neurology. 2004, Vol 51, Num 1, pp 49-50, issn 0014-3022, 2 p.Article

Risk of symptoms related to late effects of poliomyelitisREKAND, T; ALBREKTSEN, G; LANGELAND, N et al.Acta neurologica scandinavica. 2000, Vol 101, Num 3, pp 153-158, issn 0001-6314Article

Symptomatic hemidystonia of delayed onset. Magnetic resonance demonstration of pathology in the putamen and the caudate nucleusMIDGARD, R; AARLI, J. A; JULSRUD, O. J et al.Acta neurologica scandinavica. 1989, Vol 79, Num 1, pp 27-31, issn 0001-6314Article